PureTech Health plc

BATS-CHIXE:PRTCL Stock Report

Market Cap: UK£300.7m

PureTech Health Management

Management criteria checks 2/4

PureTech Health's CEO is Bharatt Chowrira, appointed in Apr 2024, has a tenure of 1.08 years. total yearly compensation is $4.31M, comprised of 18.1% salary and 81.9% bonuses, including company stock and options. directly owns 0.47% of the company’s shares, worth £1.40M. The average tenure of the management team and the board of directors is 1.2 years and 4.7 years respectively.

Key information

Bharatt Chowrira

Chief executive officer

US$4.3m

Total compensation

CEO salary percentage18.11%
CEO tenure1.1yrs
CEO ownership0.5%
Management average tenure1.2yrs
Board average tenure4.7yrs

Recent management updates

Recent updates

CEO Compensation Analysis

How has Bharatt Chowrira's remuneration changed compared to PureTech Health's earnings?
DateTotal CompensationSalaryCompany Earnings
Dec 31 2024US$4mUS$781k

US$54m

Sep 30 2024n/an/a

-US$14m

Jun 30 2024n/an/a

-US$82m

Mar 31 2024n/an/a

-US$74m

Dec 31 2023US$2mUS$575k

-US$66m

Sep 30 2023n/an/a

-US$56m

Jun 30 2023n/an/a

-US$47m

Mar 31 2023n/an/a

-US$49m

Dec 31 2022US$988kUS$530k

-US$50m

Sep 30 2022n/an/a

-US$32m

Jun 30 2022n/an/a

-US$14m

Mar 31 2022n/an/a

-US$37m

Dec 31 2021US$1mUS$500k

-US$61m

Compensation vs Market: Bharatt's total compensation ($USD4.31M) is above average for companies of similar size in the UK market ($USD1.13M).

Compensation vs Earnings: Bharatt's compensation has been consistent with company performance over the past year.

CEO

Bharatt Chowrira (59 yo)

1.1yrs

Tenure

US$4,311,555

Compensation

Dr. Bharatt M. Chowrira, J. D. Ph. D. served as Chief Business and Operating Officer at PureTech Health plc. since January 2022 until 2024 and serves as its Chief Executive Officer from April 09, 2024 and...

Leadership Team

NamePositionTenureCompensationOwnership
Bharatt Chowrira
CEO & Executive Director1.1yrsUS$4.31m0.47%
£ 1.4m
Daphne Zohar
Founderno dataUS$618.63k3.34%
£ 10.0m
Robert S. Langer
Co-Founder & Non-Executive Directorno dataUS$270.00k1.15%
£ 3.5m
Eric Elenko
Co-Founder & President1.1yrsno datano data
David Elmaleh
Co-Founder & Senior Advisorno datano datano data
Lauren White
Chief Financial Officerless than a yearno datano data
Michael Inbar
Chief Accounting Officerless than a yearno datano data
Allison Talbot
Senior VP of Communications & Head of Investor Relationsno datano datano data
Charles Sherwood
General Counsel & Company Secretary1.3yrsno datano data
Spencer Ball
Executive Vice President of Human Resources4.8yrsno datano data
Aleksandra Filipovic
Head of Oncology4.8yrsno datano data
Anita Terpstra
Senior Vice President of Intellectual Property4.8yrsno datano data

1.2yrs

Average Tenure

56yo

Average Age

Experienced Management: PRTCL's management team is not considered experienced ( 1.2 years average tenure), which suggests a new team.

Board Members

NamePositionTenureCompensationOwnership
Bharatt Chowrira
CEO & Executive Director4.3yrsUS$4.31m0.47%
£ 1.4m
Daphne Zohar
Founder1.1yrsUS$618.63k3.34%
£ 10.0m
Robert S. Langer
Co-Founder & Non-Executive Directorno dataUS$270.00k1.15%
£ 3.5m
David Elmaleh
Co-Founder & Senior Advisorno datano datano data
H. Horvitz
Board Observer9.5yrsno datano data
Raju Kucherlapati
Independent Chair of the Board11.3yrsUS$343.64k1.04%
£ 3.1m
John LaMattina
Senior Independent Director16.3yrsUS$290.00k0.63%
£ 1.9m
Dennis Ausiello
Board Advisor9.5yrsno datano data
Kiran Mazumdar-Shaw
Independent Non-Executive Director4.7yrsUS$235.00k0.021%
£ 62.4k
Michele A. Holcomb
Independent Non-Executive Directorless than a yearUS$123.65kno data
Sharon Barber-Lui
Independent Non-Executive Director3.2yrsUS$260.00k0.016%
£ 48.4k

4.7yrs

Average Tenure

72.5yo

Average Age

Experienced Board: PRTCL's board of directors are considered experienced (4.7 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/05/12 13:37
End of Day Share Price 2025/05/09 00:00
Earnings2024/12/31
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

PureTech Health plc is covered by 8 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Peter WelfordJefferies LLC
Thomas SmithLeerink Partners LLC
Faisal KhurshidLeerink Partners LLC